Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct;52(9):e13727.
doi: 10.1111/and.13727. Epub 2020 Jun 26.

The relationship between testosterone levels and Peyronie's disease

Osman Can  1 , Sait Özbir  2 , Hasan Anil Atalay  3 , Süleyman Sami Çakır  4 , Mehmet Gökhan Culha  2 , Halil Lütfi Canat  2
Affiliations

The relationship between testosterone levels and Peyronie's disease

Osman Can et al. Andrologia. 2020 Oct.

Abstract

Aetiologic and predisposing factors are still controversial about Peyronie's disease (PD). However, it is thought to be the result of connective tissue disorder or healing defect. Androgens are known to affect collagen metabolism and wound healing in the body. The aim of this study was to investigate the relationship between PD and low testosterone levels. One hundred and forty-seven Peyronie patients and 137 healthy volunteers were included in the study. In both groups, demographic data, medical history, physical examination and erectile capacity were recorded. Blood samples were collected from all subjects in the early morning hours after an overnight fast. The mean level of serum total testosterone was lower in men with PD compared with the controls (3.9 ± 1.1 vs. 4.2 ± 1.7 ng/ml respectively) (p = .062). However, statistically significant relationship was not found between PD and low serum testosterone levels. There was no significant correlation between penile plaque dimension or penile curvature degree and testosterone levels. Large randomised-controlled prospective studies are needed to reveal this possible association.

Keywords: Peyronie's disease; penile curvature; plaque; testosterone level.

PubMed Disclaimer

References

REFERENCES

    1. Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010). Testosterone therapy in men with androgen deficiency syndromes: An endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 95(6), 2536-2559. https://doi.org/10.1210/jc.2009-2354
    1. Bilgutay, A. N., & Pastuszak, A. W. (2015). Peyronie’s Disease: A Review of Etiology, Diagnosis, and Management. Current Sexual Health Reports, 7(2), 117-131. https://doi.org/10.1007/s11930-015-0045-y
    1. Bjekic, M. D., Vlajinac, H. D., Sipetic, S. B., & Marinkovic, J. M. (2006). Risk factors for Peyronie’s disease: A case-control study. BJU International, 97(3), 570-574. https://doi.org/10.1111/j.1464-410X.2006.05969.x
    1. Bratland, A., Ragnhildstveit, E., Bjornland, K., Andersen, K., Maelandsmo, G. M., Fodstad, O., … Ree, A. H. (2003). The metalloproteinase inhibitor TIMP-2 is down-regulated by androgens in LNCaP prostate carcinoma cells. Clinical and Experimental Metastasis, 20, 541-547. https://doi.org/10.1023/A:1025860214891
    1. Burnett, A. L. (1997). Nitric oxide in the penis: Physiology and pathology. Journal of Urology, 157(1), 320-324. https://doi.org/10.1016/S0022-5347(01)65369-2

LinkOut - more resources